TPSAB1

Chr 16

tryptase alpha/beta 1

Also known as: TPS1, TPS2, TPSB1, TPSB2, Tryptase-2

Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, alpha and beta 1. Beta tryptases appear to be the main isoenzymes expressed in mast cells; whereas in basophils, alpha tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
DNmechanismLOEUF 1.95
Clinical SummaryTPSAB1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
54 VUS of 98 total submissions
📖
GeneReview available — TPSAB1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.95LOEUF
pLI 0.000
Z-score -1.90
OE 1.66 (1.081.95)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-3.13Z-score
OE missense 1.74 (1.571.92)
247 obs / 142.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.66 (1.081.95)
00.351.4
Missense OE?1.74 (1.571.92)
00.61.4
Synonymous OE?1.69
01.21.6
LoF obs/exp: 16 / 9.6Missense obs/exp: 247 / 142.1Syn Z: -4.38

This gene — mechanism propensity

DN
0.6358th %ile
GOF
0.6149th %ile
LOF
0.3842th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

98 submitted variants in ClinVar

Classification Summary

VUS54
Likely Benign9
Benign34
54
VUS
9
Likely Benign
34
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
0
54
0
0
54
Likely Benign
0
5
0
4
9
Benign
0
11
18
5
34
Total07018997

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

48 pathogenic / likely-pathogenic (of 66) ClinVar copy-number / structural variants overlap TPSAB1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TPSAB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →